Hollingshead Eye Center

360 East Mallard Dr., Suite 110
Boise, Idaho 83706


Now Offering iStent for Patients with Cataracts & Glaucoma

For patients dealing with both cataracts and glaucoma, Hollingshead Eye Center offers state-of-the-art iStent technology. The iStent is the world’s smallest medical implant. It is designed to lower eye pressure by improving the eye’s natural fluid outflow and may be inserted during cataract surgery. Covered by Medicare and most private insurance plans, the iStent is a convenient way to receive treatment for both eye conditions simultaneously. It may also reduce reliance on glaucoma medication.

Learn more about glaucoma and iStent technology, then call to schedule an appointment.


We Now Offer the Raindrop Lens to Reduce Your Need for Reading Glasses

The eye's lens stiffens with age, making it is less able to focus when you view something up close. This common condition called presbyopia is the reason so many of our patients over the age of 40 come to us looking for a way to regain their near vision. They struggle with the constant hassle of having to take readers on and off, which can get in the way of daily activities.

Our Hollingshead Eye Center surgeons now offer a quick, long-term solution called the Raindrop lens, one of the latest advances in presbyopic eye care technology. The same way an image appears magnified when viewed through a drop of water, the Raindrop lens (which has similar properties and water content as the cornea) is placed beneath the cornea to improve near and intermediate vision.

Learn more about presbyopia and the Raindrop lens, then visit our Contact Us page or call (208) 336-8700 to request an appointment.


During August Hollingshead Eye Center Observes Cataract Awareness Month

Dr. Mark Hollingshead of Hollingshead Eye Center expects to be handling more questions about what a cataract is - and explaining what it is not during Cataract Awareness Month. Read the full press release.


Hollingshead Eye Center Acquires Optos Imaging Technology

Hollingshead Eye Center has acquired recently-introduced imaging technology that makes it possible to diagnose, analyze, and monitor conditions that may have otherwise gone undetected. It also provides a digital record that is particularly useful in monitoring the progression of these conditions.

“Optos 200Tx-AF® ultra-widefield imaging technology has been designed specifically for ophthalmologists and vitreoretinal specialists,” said Dr. Mark Hollingshead. “The typical manual technique for examining the retina reveals only 10 to 12 percent of it at one time. The 200Tx-AF provides a panoramic map of more than 80 percent of the retina and gives us a new avenue of information that we haven’t had until now.”

That wide, edge-to-edge view enhances an ophthalmologist’s ability to detect the earliest signs of retinal diseases, such as diabetic retinopathy and macular degeneration.

“Our continuing investment in technology gives my patients access to state-of-the-art treatment,” said Hollingshead. “When we can see more, we can do more.”

To view a video that show how this technology works, visit http://www.youtube.com/watch?v=3IX3S2vh14U.

Recent Newsletters

INSIGHT Summer 2014 Newsletter

Social Media